The Technology Development Board (TDB), under the Department of Science & Technology, Government of India, has extended financial assistance to M/s Ceramat Private Limited, Palghar, Maharashtra, for commercializing advanced 3D-printed patient-specific bone grafts. The project titled "Calcium Phosphate based Standard and Customized Patient Specific Grafts by 3D Printing via Digital Light Processing Technique and Extrusion-based Equipment" aims to develop indigenous alternatives to imported healthcare products using bioceramic materials and additive manufacturing technologies.
Ceramat Private Limited specializes in developing and commercializing indigenous technologies in bio-ceramics and advanced ceramics, with a product portfolio that includes hydroxyapatite, beta-tricalcium phosphate, biphasic calcium phosphate, and bioactive glass. These calcium phosphate-based biomaterials closely resemble the mineral composition of natural bone and are used across orthopaedics, oral care, cosmetics, and industrial sectors. While the company already manufactures bone grafts and granules through conventional processes, the new project addresses the more complex challenge of producing customized grafts matching individual patient anatomy.
The technological approach integrates 3D printing with indigenously manufactured bioceramic raw materials through two complementary methods: Digital Light Processing (DLP)-based 3D printing and extrusion-based 3D printing. These technologies enable greater flexibility in developing complex geometries and customized structures suited to specific clinical requirements, expanding Ceramat's capabilities from conventional graft products to sophisticated, digitally designed patient-specific solutions.
The initiative is aligned with the Government of India's Aatmanirbhar Bharat program, emphasizing advanced manufacturing and indigenous medical technology development. By establishing patient-specific graft manufacturing capabilities domestically, the project aims to reduce dependence on imported bioceramic and orthobiological products, strengthen domestic supply chains, and create a platform with potential for global markets. Shri Rajesh Kumar Pathak, Secretary of TDB, emphasized that India's transition from technology consumer to technology developer requires indigenous capabilities in specialized healthcare areas, and that TDB is committed to supporting technologies that bring Indian innovation from development to commercial application.